Background and Aims: The transcription factor Nrf2 is a major modulator of the cellular antioxidant response. Oxidative burst of infiltrating macrophages leads to a massive production of reactive oxygen species in inflamed tissue of inflammatory bowel disease patients. This oxidative burst contributes to tissue destruction and epithelial permeability, but it is also an essential part of the antibacterial defence. We therefore investigated the impact of the Nrf2 orchestrated antioxidant response in both acute and chronic intestinal inflammation. Methods: To study the role of Nrf2 overexpression in mucosal inflammation, we used transgenic mice conditionally expressing a constitutively active form of Nrf2 [caNrf2] either in epithelial cells or in the myeloid cell lineage. Acute colitis was induced by dextran sulphate sodium [DSS] in transgenic and control animals, and changes in gene expression were evaluated by genome-wide expression studies. Long-term effects of Nrf2 activation were studied in mice with an IL-10 -/-background. Results: Expression of caNrf2 either in epithelial cells or myeloid cells resulted in aggravation of DSSinduced acute colitis. Aggravation of inflammation by caNrf2 was not observed in the IL-10 -/-model of spontaneous chronic colitis, where even a trend towards reduced prolapse rate was observed. Conclusions: Our findings show that a well-balanced redox homeostasis is as important in epithelial cells as in myeloid cells during induction of colitis. Aggravation of acute DSS colitis in response to constitutive Nrf2 expression emphasises the importance of tight regulation of Nrf2 during the onset of intestinal inflammation.
Introduction
Inflammatory bowel diseases [IBD] are inflammatory, relapsing disorders of the gastrointestinal tract. The two major forms, Crohn´s disease [CD] and ulcerative colitis [UC] , affect a rising number of patients worldwide. 1 IBD pathogenesis is still not fully understood; the current concept is that IBD results from an inappropriate and continuing inflammatory response to commensal microbes in a genetically susceptible host triggered by environmental factors. 2 In acute mucosal inflammation, reactive oxygen species [ROS] are produced by infiltrating macrophages and neutrophils as part of the antibacterial response. 3 Basal levels of ROS are not toxic and they act as signalling molecules, influencing various pathways such as NF-κB or inflammasome signalling. 4 Furthermore, ROS are needed to maintain the intestinal stem-cell niche. 2 Conversely, an excessive formation of ROS can lead to tissue destruction, further exacerbating the pathology of IBD. 5 There is evidence for a direct impact of oxidative stress on the pathogenesis of IBD, such as increased ROS formation in the colonic mucosa in animal models of IBD 6 and IBD patients. 7 Furthermore, a depletion of antioxidants in serum of IBD patients and an increase in biomarkers for oxidative damage have been observed. 3 Genetically modified mouse models revealed a protective role of the overexpression of antioxidant enzymes, such as zinc-superoxide dismutase or copper-superoxide dismutase, and an increased susceptibility towards tissue destruction in mice deficient in ROS-detoxifying enzymes, e.g. glutathione peroxidase-1. 8 Several genes that were identified as IBDassociated loci in genome-wide association studies encode proteins that are involved either in the regulation of ROS production or in protection against oxidative stress.
2 In particular, nucleotide-binding oligomerisation domain-containing protein 2 [NOD2], 9 caspase recruitment domain-containing protein 9 [CARD9], 10 and IFN-γ-regulated leucine-rich repeat kinase 2 [LRRK2] 11 contribute to ROS production.
A key player in the antioxidant response is the transcription factor 'nuclear factor erythroid derived 2, like 2' [Nrf2], which activates various genes encoding antioxidant proteins and type II detoxification enzymes. 12 Under basal conditions Nrf2 is bound to Keap1, leading to a rapid ubiquitinylation and subsequent proteasomal degradation of Nrf2. 13 A conformational change in Keap1 triggered by the coupling of electrophiles to the protein results in a weakening of the Nrf2-Keap1 interaction. This causes stabilisation of Nrf2, and newly formed protein accumulates in the nucleus where it binds to antioxidant response elements [ARE] in the promoter of Nrf2 target genes. 14 14 and enzymes involved in glutathione biosynthesis, e.g. glutamate-cysteine ligase, catalytic subunit [Gclc] , and modifier subunit [Gclm] . 16 The crucial role of Nrf2 in mucosal inflammation in vivo is reflected by the results obtained from Nrf2 knockout mice. Lack of Nrf2 leads to a higher susceptibility to dextran sulphate sodium [DSS]-induced colitis 17 and azoxymethane [AOM]/DSS colitis associated colorectal carcinoma [CRC] . 18 Also, other inflammatory diseases show an aggravated course of disease in the absence of Nrf2, such as lung inflammation induced by cigarette smoke, pneumonia, or endotoxic shock upon lipopolysaccharide [LPS] injection. 19 However, recent studies have also shown negative aspects of high Nrf2 activity. An aberrant activation of Nrf2 through either loss-of-function mutations in the Keap1 gene or gain-of-function mutations in the Nrf2 gene occurs in a wide range of human cancers, and seems to provide advantages for tumour growth. [20] [21] [22] In animal models of atherosclerosis a protective effect of Nrf2 knockout could be observed, 23 and in mice lacking leptin an increased Nrf2 activity leads to an exacerbation of hepatic steatosis. 24 To study the conflicting role of Nrf2 in inflammation, we used transgenic mice expressing a constitutively active Nrf2 mutant [caNrf2] in two cell lineages that are known to be sources of ROS in mucosal inflammation, namely epithelial cells and myeloid cells. 8 The influence of tissue-specific activation of Nrf2-mediated gene expression in colitis was studied in the acute model of DSS-induced mucosal inflammation, as well as in the chronic interleukin 10 [IL-10] knockout model.
Materials and Methods

Mouse model
CMVcaNrf2 mice allowing for conditional expression of a constitutively active Nrf2 [caNrf2] mutant has been described previously. 25, 26 By crossing CMVcaNrf2 mice with either VilCre or LysMCre mice, expression of caNrf2 was achieved either in epithelial cells 27 or in the myeloid lineage. 28 Mice were kept under specific pathogen-free conditions in the animal facility of the University Hospital Zurich with access to food and water ad libitum. As a model for chronic mucosal inflammation we used IL-10 knockout mice. Spontaneous development of chronic colitis in IL-10 knockout mice is dependent on the inbred strain background and the microbial environment. Therefore, different models have been developed to trigger the spontaneous colitis in the colitis-resistant C57Bl/6 strain under clean housing conditions. 29 In our study, onset of inflammation was triggered by administration of 3% DSS for 3 days in the drinking water at the age of 8 weeks, as described by Michael et al. previously. 30 Animals were subsequently monitored for 8 weeks for the occurrence of rectal prolapse. Animals that did not develop a prolapse during this period were sacrificed and body weight, colon length, spleen weight, and histological score were assessed. 38 In brief, deproteinised cytosolic extracts of tissue samples were obtained by mechanical homogenisation in extraction buffer [0.1% Triton X-100 and 0.6% sulphosalicylic acid in 0.1M potassium phosphate buffer with 5 mM EDTA disodium salt, pH 7.5]. After centrifugation at 2 000 rpm for 5 min at 4°C, the resultant supernatant was added to 120 µl of DTNB and glutathione reductase solution. After 30 s, 30 µl of β-NADPH was added. The absorbance of the supernatant was measured at 412 nm against a reagent blank. The amount of total GSH was expressed as ng/mg protein.
Isolation of intestinal epithelial cells [IEC]
IECs were isolated as described previously 39 
Statistical analysis
Statistical analysis was performed with the statistical software package SPSS Version 22 using the Mann-Whitney rank sum test for nonparametrically distributed samples. Box plots express median, 25% quartiles, minimum and maximum. Differences were considered significant at p < 0.05 [*], highly significant at p < 0.01 [**], and very highly significant at p < 0.001 [***].
Results
Expression of caNrf2 in epithelial cells aggravates acute intestinal inflammation
Intestinal epithelial cells form a tight layer of specialised differentiated cells separating the colon content from the subepithelial lamina propria, thereby playing an important role in the development of IBD as a structural as well as an immunophysiological barrier. 41 To investigate the role of Nrf2 pathway activation in this cell lineage, animals carrying a Cre inducible transgene coding for caNrf2 under a beta-actin promoter and a CMV enhancer 25 were crossbred with VilCre mice to achieve expression of caNrf2 in epithelial cells. We studied the expression of Nrf2 and its target genes to evaluate the level of activation of Nrf2-dependent pathways. Expression of total Nrf2 was 2.46-fold higher in epithelial cells isolated from Next, we induced an acute colitis in this mouse model by administration of 2.5 % DSS in the drinking water either in VilCre or in VilCre-CMVcaNrf2 mice. Mice expressing caNrf2 in epithelial cells lost 10.8 +/-0.6% of their body weight during colitis, whereas control animals showed a significantly lower weight loss Figure 1C ]. In contrast, colonoscopy on Day 8 showed no differences between mice expressing caNrf2 and control animals [ Figure 1D ]. Also, MPO activity did not differ between groups [ Figure 1E ]. Our data show that over-activation of Nrf2 in epithelial cells has adverse effects in acute DSS colitis.
Expression of caNrf2 in macrophages aggravates acute intestinal inflammation
Given the negative effect of caNrf2 expression in epithelial cells, we sought to investigate whether expression of caNrf2 in macrophages also affects the outcome of acute colitis.
For this purpose, CMVcaNrf2 mice were crossbred with the LysMCre strain, achieving an expression of caNrf2 in the myeloid cell lineage. To control for Nrf2 expression in the targeted cell lineage, we studied the expression of Nrf2 and Nrf2 target genes in BMDM [Supplementary Figure 1 Figure 2C ]. However, no significant difference was observed in colon length on Day 8 [ Figure 2B ]. Colonoscopy score and MPO activity also did not differ between groups [ Figure 2D and E].
Thus, enhanced expression of Nrf2 target genes either in myeloid cells or in epithelial cells aggravated the course of acute DSS, indicating that both cell lineages require a balanced Nrf2 activation to limit excessive inflammation.
Cytokine expression in the colon differs in mice expressing caNrf2 in epithelial cells or myeloid cells
To further study the regulation of inflammation in VilCreCMVcaNrf2 and LysMCre-CMVcaNrf2, the expression of mRNAs coding for iNOS and the cytokines IFN-γ, TNF, IL-6, IL-1β, and IL-10 in the colon was analysed. Mice expressing caNrf2 in epithelial cells showed significantly reduced expression of TNF [0. 46- 
A typical pattern of Nrf2 target genes is regulated in response to acute DSS-induced inflammation and by caNrf2 expression
To assess global changes in mRNA expression pattern in response to caNrf2 expression, RNA samples from epithelial cells of VilCreCMVcaNrf2 and control animals were analysed by genome-wide expression study [RNAseq] . Additionally, changes in gene expression in response to caNrf2 expression and to acute intestinal inflammation were studied in whole colon wall samples [ As expected, the heat map diagram of all samples showed the biggest differences between epithelial cell and whole colon wall specimens and between non-inflamed vs. expressed in whole colon wall samples of caNrf2 expressing mice as well as of control mice. In VilCre-CMVcaNrf2 mice treated with DSS, the expression of 3263 genes was significantly changed in comparison with non-inflamed VilCre-CMVcaNrf2 animals. The expression of 3099 genes was changed in response to DSS colitis in VilCre control animals; 2244 were found to overlap between both groups. As induction of Nrf2 in response to DSS colitis can be observed in VilCre animals, DSS colitis also altered the expression of 241 Nrf2 target genes in these WT controls. In caNrf2-expressing animals in comparison, DSS colitis led to regulation of 244 Nrf2 target genes. There was an overlap of 171 colitis-responsive Nrf2 target genes between VilCre-CMVcaNrf2 and Vil-Cre animals, whereas regulation of 74 Nrf2 target genes was exclusively observed in DSS-treated VilCre-CMVcaNrf2 mice, and 71 Nrf2 target genes were affected by DSS colitis in Vil-Cre control animals only [ Figure 4B ; Supplementary Table 1 ]. These findings show that the antioxidative response orchestrated by Nrf2 is activated during DSS colitis. On the other hand, a different subset of Nrf2 target genes is changed in their expression in caNrf2-expressing mice, which could explain differences in susceptibility to DSS-induced colitis.
We used the pathway analysis tool DAVID 36 to identify affected processes in the small subset of genes that was differentially expressed between VilCre-caNrf2 and VilCre mice. Pathway analysis revealed that mainly mRNAs involved in glutathione metabolism, oxidoreductases, and enzymes for xenobiotics and drug metabolism were enriched [ Table 1 ], which is in concordance with reported pathways responsive to Nrf2 activation. 35 Although we had observed mild aggravation of colitis in VilCre-caNrf2 animals, the pro-inflammtory cytokine IL1f9 was the only mRNA that could be associated with increased inflammation in the VilCre-caNrf2 animals. On the contrary, glutathione metabolism was most strongly affected with 9 of the 30 differentially expressed genes being involved in this process. VilCre-caNrf2 animals showed consistent overexpression of glutathione metabolism-related mRNAs. To address whether increased mRNA expression of enzymes involved in glutathione synthesis leads to increased GSH tissue levels, we analysed total GSH in colon tissue samples. However, no differences in GSH content between genotype or between inflamed vs. non-inflamed animals were observed in mice with epithelial overexpression of Nrf2. In LysMCre-caNrf2 animals, GSH levels were increased in inflamed wild-type controls whereas they were not affected in transgenic animals [ 
Expression of caNrf2 in epithelial cells or myeloid cells does not aggravate chronic colitis
To investigate the effect of constitutive Nrf2 activation in the setting of chronic colitis, the caNrf2 transgene was bred into the IL-10 knockout background and activated in intestinal epithelial cells or myeloid cells as described above. To monitor the level of activation of Nrf2-dependent pathways, expression of total Nrf2 and the target genes Nqo1, Gss, and Gclm were assessed. Interestingly, no significant changes in expression of Nrf2 target genes, except for an up-regulation of GSS in VilCre-CMVcaNrf2/IL-10 -/-female mice, could be observed [fold change 1.29, p = 0.0338]. Total Nrf2 expression was 1.77-fold increased [p < 0.0001] in LysMCreCMVcaNrf2/IL-10 -/-whereas no significant change could be observed in the other groups. However, only total colon samples To study the influence of caNrf2 expression on chronic colitis development, we monitored rectal prolapse incidence in animals with IL-10 knockout background. No difference was found in the prolapse rate of male VilCre-CMVcaNrf2/IL -10 -/-mice as compared with VilCre/IL-10 -/-, whereas female VilCre-CMVcaNrf2/IL-10 -/-mice showed a trend towards a reduced prolapse occurrence in female VilCre/IL-10 -/-[15% vs. 21%] [ Figure 5A ]. Likewise, male mice expressing caNrf2 in myeloid cells showed no differences in prolapse rate compared with male control animals, whereas in female mice a trend towards lower prolapse occurrence was observed [15% vs. 24%] [ Figure 6A ].
Eight weeks after triggering of spontaneous colitis by DSS, animals that had not yet developed a prolapse were euthanised and body weight, colon length and spleen weight were measured. No differences in these parameters were found in VilCreCMVcaNrf2/IL-10 -/-[ Figure 5B -D] or in LysMCre-CMVcaNrf2/ IL-10 -/-mice [ Figure 6B -D] as compared with the respective IL-10 -/-controls. The histology score did not differ between VilCre/ IL-10 -/-and VilCre-CMVcaNrf2/IL-10 -/-[ Figure 5E ]. In contrast, female LysMCre-CMVcaNrf2/IL-10 -/-mice showed a significantly reduced histology score as compared with LysMCre/IL-10 -/-mice [ Figure 6E ].
These data indicate that in contrast to the acute colitis model there is no evidence for aggravation of inflammation, but in some parameters a trend towards an amelioration of chronic colitis in animals expressing caNrf2 in epithelial cells or myeloid cells. 
Cytokine expression and GSH levels in
Discussion
ROS produced during oxidative burst are very reactive molecules that can damage cellular components. On the other hand, ROS present in low concentrations are involved in various signalling pathways that can even protect from oxidative stress by inducing 'redox homeostasis'. 42 Furthermore, ROS are necessary at the mucosal interface to prevent invasion of bacteria into the intestinal wall and the body.
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Nrf2 is a master regulator of the antioxidant response in cells. We here investigated its role in mucosal inflammation. Our findings, that the expression of a large number of Nrf2 target genes is changed in response to induction of inflammation by DSS, confirm the importance of Nrf2-regulated genes in inflammation. In the present study we also show that further activation of Nrf2-mediated gene expression in epithelial cells as well as in myeloid cells leads to aggravation of acute DSS colitis. We hypothesise that, although excessive ROS production during the onset of mucosal inflammation is assumed to contribute to pathogenesis, tight regulation of the antioxdative defence is necessary. In contrast, in the IL-10 -/-model of chronic colitis, even a trend towards reduced prolapse rates and reduced mucosal damage could be observed in response to Nrf2 activation. In a chronic model with sustained ROS production as a consequence of inflammation, the protective effects of constitutive Nrf2 overexpression seem to prevail. These findings suggest different roles of Nrf2 activation during acute and chronic mucosal injury. Alternatively or in addition, a different set of Nrf2 target genes could be regulated during acute vs. chronic inflammation.
Infiltration of inflammatory cells, such as neutrophils and macrophages, is a hallmark of disease pathophysiology in IBD. 44 Myeloid cells are a main source of ROS during mucosal inflammation, generated by NAD[P]H oxidase 2 [NOX2] and iNOS. In addition, epithelial cells express NOX enzymes, mainly NOX1 and Duox2, and iNOS in response to inflammatory cytokines. 8 The oxidative stress caused by these sources can directly damage epithelial cells and thereby disrupt the epithelial barrier. 5 Furthermore, oxidative stress can also cause a dysregulation of redox signalling, for example by activating the NF-κB pathway with a subsequent overproduction of pro-inflammatory cytokines. 3 However, the importance of ROS production for maintenance of intestinal homeostasis has been shown as rare hypomorphic variants of NOX1, NOX2, and DUOX2 increase the susceptibility to very early-onset inflammatory bowel disease. 45, 46 Our results are in contrast to the common notion that Nrf2 activation is beneficial during colitis induction Khor et al. 47 have demonstrated that the induction of acute DSS colitis in mice lacking Nrf2 leads to an aggravated mucosal inflammation. They concluded that Nrf2 could be a target for protection of intestinal integrity. Furthermore, several studies observed an amelioration of acute DSS colitis by application of Nrf2-activating substances like sulphoraphane or gallic acid. 48, 49 The treatment with sulphoraphane during acute DSS-induced colitis led to reduced weight loss, less colon shortening and lower disease activity index. 48 Apparently, the induction of Nrf2 by natural components has not the same deleterious effects on mucosal inflammation as we see in our experiments, maybe due to an increase in Nrf2 activity that is more counterbalanced by the cell. Also sulphoraphane not only activates Nrf2, but has been shown to directly activate the MAPK pathway 50 and induce the expression of various genes independently of Nrf2. 51 Furthermore, the activiation of Nrf2 by sulphoraphane is transient in contrast to a genetic activation. 52 Our data indicate that constitutive genetic activation of Nrf2 in intestinal epithelial cells as well as in myeloid cells aggravates the inflammation during acute DSS colitis. The effect on colitis severity was very similar in both models of tissue-specific activation of Nrf2, suggesting that a balanced redox homeostasis is equally important during induction of acute colitis in both cell types.
Another model to study Nrf2 activation is the genetic disruption of Keap1. The general knockout of Keap1 is lethal due to hyperkeratosis of the oesophagus and forestomach, disruption-mediated Nrf2 activation could be seen in fatty liver development, 53 development of oxidative stress after starvation, 54 or inflammation in the lung after cigarette smoke administration. 55 On the other hand, other reports confirm our findings of negative effects of Nrf2 activation, for example worsening of insulin resistance and elevated hepatic steatosis in leptin-deficient mice. 24 Again, the disruption of Keap1 is not only followed by Nrf2-specific effects, but may also have Nrf2-independent effects, such as increased IL-6 expression in monocytes/macrophages as described by Lv et al. 56 or the activation of NF-κB via binding of Keap1 to IKK. 57 Constitutive caNrf2 expression in other tissues revealed that its expression in hepatocytes impairs liver regeneration after partial hepatectomy. 58 Expression in neurons and muscle cells had no beneficial effect on survival in amyotrophic lateral sclerosis. 59 Furthermore, expression in keratinocytes produced severe skin abnormalities, including hyperkeratosis of the epidermis and hair follicle infundibula as well as tumorigenic effects in early phases of skin tumorigenesis. 25, 60, 61 Schäfer et al. linked the deleterious effects on the skin to a more than 100-fold increase of Slpi in keratinocytes, an important protease inhibitor that prevents stratum corneum desquamation. 25 We did not observe the same strong induction of Slpi Nevertheless, the finding that constitutive Nrf2 activation has deleterious effects in various tissues and disease models underlines the importance of tight regulation of Nrf2 activity. Over the past few years, additional mechanisms of Nrf2 negative regulation independent of Keap1 have been identified, the most important being via the GSK-3β/ β-TrCP-Skp1-Clul1-Rbx1 E3 ubiquitin ligase and via the Hrd E3 ubiquitin ligase. 62 Further mechanisms of Nrf2 regulation include transcriptional regulation, post-transcriptional regulation by microRNAs, and post-translational modification by phosphorylation and acetation. The protein immediate early response-3 [IER3] has been shown to be an important negative regulator of Nrf2 in colonic epithelial cells, as knockout of IER3 led to an increase in Nrf2 activity and to a more severe disease phenotype in the DSS colitis model. 63, 64 We found IER3 up-regulated during DSS colitis in both Vil-Cre [1.4-fold] and Vil-Cre-caNrf2 [2.2-fold] animals. The higher induction of IER3 in the Vil-Cre-caNrf2 animals might be interpreted as an effort of the cell to counteract the constitutive Nrf2 overexpression. Constitutive Nrf2 activation has been observed in various tumour cells, including colon cancer, whereas prolonged Nrf2 activation results from autophagy dysfunction via p62-mediated Keap1 inactivation and is thought to contribute to arsenic-induced carcinogenesis. These findings led to the concept that physiological, protective Nrf2 function results from intermittent Nrf2 activation. The pharmacological Nrf2 activation, for example by sulphoraphane, corresponds to such an intermittent activation, whereas our model of constitutive genetic Nrf2 activation does not.
In contrast to the various findings that support the notion that constitutive Nrf2 activation disturbs the redox balance, we did not observe a worsening of mucosal inflammation in the chronic colitis model of IL10 knockout mice upon expression of caNrf2 in either epithelial or myeloid cells. We can only assume that in the setting of chronic colitis, Nrf2 activation acts beneficially against the prolonged inflammation-associated ROS production. We did not observe any signs of increased colonic tumour formation, as might be anticipated as a consequence of constitutive Nrf2 overexpression. Probably the time span studied was too short to detect effects on tumour formation.
Even though we saw the same clinical effects on inflammation in VilCre-CMVcaNrf2 and LysMCre-CMVcaNrf2 mice, we observed a different cytokine expression pattern under basal conditions. Expression of caNrf2 in the myeloid lineage showed a trend towards induction of cytokines as in the control [except for IL-1β], whereas in mice with epithelial expression of caNrf2, TNF and IL-6 were significantly down-regulated. Over the past few years, complex interactions between Nrf2 and the NF-κB response pathways have been identified, 65 yet we can only speculate about the mechanisms that led to differential expression of cytokines in response to overexpression of Nrf in epithelial or myeloid cells. Hoetzenecker et al. reported that Nrf2 is required for activation of ATF3 that in turn inhibits the transcription of IL-6. 66 Another recent study showed the existence of a highly conserved mechanism by which commensal bacteria of the genus Lactobacillus, but not pathogens, stimulate the formation of ROS in the intestine of Drosophila and mice and in cultured human epithelial cell lines. This ROS induction leads to proliferation of epithelial cells and may be mediated by the pro-mitogenic cytokine IL-6. 67 One could speculate that in our VilCrexCMVcaNrf2-male VilCrexCMVcaNrf2-female LysMCrexCMVcaNrf2-male LysMCrexCMVcaNrf2-female mouse model the permanent high activation of Nrf2 led to excessive detoxification of ROS produced by certain commensal bacteria, thereby leading to a higher susceptibility to DSS-induced acute colitis.
Our studies of the mRNA expression profile in epithelial cells of caNrf2-expressing mice and controls revealed that in epithelial cells as well as in the whole colon wall, not only the expression of direct targets of Nrf2 is changed, but also secondary effects could be observed. When inflamed total colon samples of VilCreCMVcaNrf2 mice are directly compared with inflamed colon samples of control animals, an enrichment of gene products active in glutathione metabolism, oxidoreductase activity, of drug and xenobiotic pathways could be observed, which is in concordance with findings in mouse embryonic stem cells lacking Keap1. 35 The tripeptide glutathione is the most important antioxidant of the intestinal mucosa, and glutathione levels have been shown to be reduced in inflamed mucosa of inflammatory bowel disease patients. 68 Furthermore, elevation of glutathione levels by supplementation of N-acetylcysteine led to less severe course of disease in animal models of acute colitis. 69, 70 To investigate whether enhanced expression of enzymes involved in glutathione synthesis and metabolism translates into differences in tissue glutathione levels, we assessed total GSH levels. In contrast to our findings at mRNA level, tissue glutathione levels were not affected in mice with epithelial overexpression of Nrf2, either at baseline or upon induction of DSS colitis. In mice with myeloid overexpression of Nrf2, on the other hand, total GSH levels were increased in inflamed wild-type controls but not in the transgenic animals. These results are in contrast to what might be expected with regard to enhanced mRNA levels of enzymes involved in glutathione synthesis, yet they might explain the less severe course of disease in wild-type animals. In the IL-10 knockout model we did not see any differences in glutathione levels in male mice, whereas female IL-10 knockout animals had higher colonic GSH levels in comparison with both LysMCre-CMVcaNrf2/IL-10 -/-and VilCre-CMVcaNrf2/IL-10 -/-animals. To our knowledge, little is known about intestinal glutathione levels in the IL-10 knockout model or how it affects the course of disease. Still, it is striking that elevated glutathione levels are associated with a more severe course of disease in our study. Whether this is just a coincidence or whether alterations in glutathione levels are causally involved in disease pathogenesis in the IL-10 knockout model will need to be addressed in more detailed studies. At the moment it can only be speculated why Nrf2-overexpressing animals show no increase in glutathione levels, despite Nrf2-mediated induction of enzymes involved in glutathione synthesis. Further studies should investigate whether GSH secretion into the gut lumen, impaired [re-]absorption of amino acids for GSH synthesis, or increased consumption of GSH within the tissue contribute to the effect.
In summary, we show that genetic activation of Nrf2 either in epithelial cells or in myeloid cells aggravates acute mucosal inflammation, which is in contrast to the effect in a chronic IL-10 -/-model. These findings indicate that, upon acute mucosal damage and barrier defect, tight regulation of the redox balance is of importance and that both an excessive production of ROS and an over-induction of antioxidant enzymes can be deleterious. Potential Nrf2-targeted therapies for IBD patients thus may be more beneficial for maintenance of remission, but not for acute flares of the disease.
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